Literature DB >> 24556735

Stopping antiepileptic drugs in seizure-free patients.

Kees P J Braun1, Dieter Schmidt.   

Abstract

PURPOSE OF REVIEW: Based on the available evidence, we aim to balance risks and benefits of antiepileptic drug (AED) withdrawal in medically and surgically treated adults and children who achieved remission. We summarize risks and predictors of seizure relapse after AED withdrawal and chances of not regaining seizure freedom. Finally, we discuss how AED discontinuation can inform us on the natural course of the epileptic disorder. RECENT
FINDINGS: In medically treated patients, the risk of recurrence after AED withdrawal is increased until 2 years after withdrawal, although long-term seizure outcomes seem to be unaffected by drug policies. Most relapses occur during the first year after withdrawal. Several predictors of postwithdrawal relapse have been identified. The risk of developing uncontrollable epilepsy following withdrawal is less than one in five. Whether AED withdrawal after epilepsy surgery contributes to seizure outcome has never been studied in a randomized controlled manner. Recent studies suggested that AED reduction merely unmasks incomplete surgical success. The risk of not regaining seizure freedom after postoperative relapse is around 30% and probably not affected by AED reduction. Timing of AED discontinuation does not influence eventual seizure outcomes.
SUMMARY: There is no proof that AED withdrawal itself negatively affects long-term seizure outcomes in patients who became seizure-free under AED treatment or after epilepsy surgery. AED discontinuation unveils the natural history of the epilepsy in medically treated patients, and the completeness of resection of the epileptogenic network in patients who underwent epilepsy surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24556735     DOI: 10.1097/WCO.0000000000000075

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  6 in total

1.  Practice Current: When do you stop antiepileptic drugs in patients with genetic generalized epilepsies and in those with focal epilepsies?

Authors:  Luca Bartolini
Journal:  Neurol Clin Pract       Date:  2016-12

2.  Deciding When Less Is More: The Crossroads of Withdrawing Antiepileptic Drugs.

Authors:  Naymee Velez Ruiz
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

3.  Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo.

Authors:  Housseini Dolo; Michel Mandro; Deogratias Wonya'Rossi; Francoise Ngave; Jessica Fraeyman; Joseph N Siewe; Patrick Suykerbuyk; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2018-12-04       Impact factor: 4.520

4.  Cognitive performance in distinct groups of children undergoing epilepsy surgery-a single-centre experience.

Authors:  Barbora Benova; Anezka Belohlavkova; Petr Jezdik; Alena Jahodová; Martin Kudr; Vladimir Komarek; Vilem Novak; Petr Liby; Robert Lesko; Michal Tichý; Martin Kyncl; Josef Zamecnik; Pavel Krsek; Alice Maulisova
Journal:  PeerJ       Date:  2019-10-08       Impact factor: 2.984

5.  Cost-effectiveness of surgery for drug-resistant temporal lobe epilepsy in the US.

Authors:  Shehryar R Sheikh; Michael W Kattan; Michael Steinmetz; Mendel E Singer; Belinda L Udeh; Lara Jehi
Journal:  Neurology       Date:  2020-07-08       Impact factor: 9.910

6.  Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy.

Authors:  Zhiliang Fan; Xiaojuan Feng; Zhigang Fan; Xingyuan Zhu; Shaohua Yin
Journal:  Mol Med Rep       Date:  2018-05-09       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.